Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
30.37
-1.24 (-3.92%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Tectonic Therapeutic Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
60
Market Cap
573.06M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zevra Therapeutics | 122.29M |
| ARS Pharmaceuticals | 98.99M |
| REGENXBIO | 87.82M |
| Prime Medicine | 4.03M |
| Shattuck Labs | 1.00M |
| Altimmune | 36.00K |
| Allogene Therapeutics | 22.00K |
TECX News
- 6 weeks ago - Tectonic Therapeutic completes enrollment for APEX trial - TheFly
- 6 weeks ago - Tectonic Therapeutic Completes Enrollment in TX45 APEX Phase 2 Clinical Trial in PH-HFpEF Patients - GlobeNewsWire
- 6 weeks ago - Tectonic Therapeutic Transcript: AGM 2026 - Transcripts
- 2 months ago - Tectonic Therapeutic upgraded to Strong Buy from Outperform at Raymond James - TheFly
- 2 months ago - Tectonic Therapeutic Announces First Quarter 2026 Financial Results and Recent Business Highlights - GlobeNewsWire
- 2 months ago - Tectonic Therapeutic Quarterly report: Q1 2026 - Filings
- 2 months ago - Tectonic Therapeutic Earnings release: Q1 2026 - Filings
- 2 months ago - Tectonic Therapeutic Slides: Investor presentation - Filings